SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study
The Lancet,
BackgroundVaccines offer people with multiple sclerosis (PwMS) an effective protection against severe COVID-19 disease courses.